NN
NanoViricides, Inc.
NNVC · AMEX
$1.42 +1.43% (+$0.02)
1M +11.81%
Market Cap $36.1M
P/E Ratio -
Div. Yield -
ROE 92.69%
Bulios Fair Price
$1.24
12.7% downside
Current Price
$1.42
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NNVC is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
51 /100
Fair P/B 3.94x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 31.20%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 89.32%
Asset turnover 0.00x
ROE 92.69%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 3.17x
Int. coverage N/A
Stability
51 /100
Moderate Beta 1.66x
Profitable years 0
EPS volatility 8.08%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NNVC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Anil R. Diwan
Employees
7
Headquarters
Shelton
Upcoming events
05 OCT
Earnings
Upcoming earnings report